What is Nvidia’s New $1 Trillion SuperProject?

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

ORIC Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.55%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $339,287.96

ORIC Pharmaceuticals Insider Trading History Chart

ORIC Pharmaceuticals Share Price & Price History

^$9.65

▲ +0.17 (1.79%)

As of 09/6/2024 01:00 AM ET

Days: 30 | 90 | 365

Perfect Crypto Buying Opportunity for 50 Cents

From Crypto 101 Media | Ad

When cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious Bank

Go here to get full details on this crypto now.

ORIC Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/6/2024	Jacob Chacko	CEO	Sell	13,958	$12.12	$169,170.96	794,586
12/15/2023	Jacob Chacko	CEO	Sell	14,539	$8.58	$124,744.62	808,544
12/15/2023	Pratik S Multani	Insider	Sell	5,282	$8.59	$45,372.38	23,809
7/10/2023	Jacob Chacko	CEO	Sell	10,508	$8.01	$84,169.08	785,808
7/5/2023	Jacob Chacko	CEO	Sell	4,336	$8.01	$34,731.36	796,316
6/26/2023	Jacob Chacko	CEO	Sell	20,000	$8.03	$160,600.00	800,652
12/15/2022	Jacob Chacko	CEO	Sell	5,764	$3.25	$18,733.00	817,025
12/15/2022	Pratik S Multani	Insider	Sell	2,089	$3.25	$6,789.25	7,423
5/13/2022	Jacob Chacko	CEO	Buy	76,072	$2.82	$214,523.04	802,652
5/11/2022	Jacob Chacko	CEO	Buy	304,574	$2.90	$883,264.60	657,226
3/31/2022	Dominic Piscitelli	CFO	Buy	60,000	$5.36	$321,600.00
3/25/2022	Jacob Chacko	CEO	Buy	50,000	$4.54	$227,000.00
3/23/2022	Jacob Chacko	CEO	Buy	257,127	$4.98	$1,280,492.46
9/15/2021	Jacob Chacko	CEO	Sell	3,736	$25.06	$93,624.16	6,388
9/14/2021	Richard A. Heyman	Director	Sell	706	$25.05	$17,685.30	12,500
9/13/2021	Jacob Chacko	CEO	Sell	2,801	$25.02	$70,081.02	6,388
9/10/2021	Jacob Chacko	CEO	Sell	2,942	$25.08	$73,785.36
9/7/2021	Jacob Chacko	CEO	Sell	5,981	$25.11	$150,182.91	16,751
9/7/2021	Richard A Heyman	Director	Sell	1,086	$25.11	$27,269.46	12,500

“Fed Proof” Your Bank Account with THESE 4 Simple Steps

From Weiss Ratings | Ad

Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.

Learn these 4 simple steps and protect your savings before it’s too late.

SEC Filings (Institutional Ownership Changes) for ORIC Pharmaceuticals (NASDAQ:ORIC)

95.05% of ORIC Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ORIC Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	The Manufacturers Life Insurance Company	131,350	$0.93M	0.0%	+7.7%	0.195%
8/15/2024	Millennium Management LLC	782,299	$5.53M	0.0%	+297.4%	1.160%
8/15/2024	AQR Capital Management LLC	12,241	$87K	0.0%	-14.4%	0.018%
8/14/2024	Squarepoint Ops LLC	33,984	$0.24M	0.0%	+95.6%	0.050%
8/14/2024	Fred Alger Management LLC	155,912	$1.10M	0.0%	-29.1%	0.231%
8/14/2024	Profund Advisors LLC	21,861	$0.16M	0.0%	+23.6%	0.032%
8/12/2024	XTX Topco Ltd	21,638	$0.15M	0.0%	N/A	0.032%
8/9/2024	Renaissance Technologies LLC	47,000	$0.33M	0.0%	-57.6%	0.070%
8/9/2024	Dimensional Fund Advisors LP	466,662	$3.30M	0.0%	+190.2%	0.692%
8/8/2024	First Turn Management LLC	1,515,960	$10.72M	1.7%	+38.1%	2.248%
8/8/2024	Cornercap Investment Counsel Inc.	21,738	$0.15M	0.0%	N/A	0.032%
8/8/2024	American Century Companies Inc.	84,201	$0.60M	0.0%	+15.1%	0.125%
8/7/2024	Monaco Asset Management SAM	301,650	$2.13M	0.3%	+132.0%	0.447%
8/6/2024	Quest Partners LLC	10,378	$73K	0.0%	+253.2%	0.015%
8/5/2024	Victory Capital Management Inc.	95,850	$0.68M	0.0%	+8.3%	0.142%
8/3/2024	TD Asset Management Inc	139,400	$0.99M	0.0%	-33.2%	0.207%
8/1/2024	Rhumbline Advisers	92,702	$0.66M	0.0%	+53.7%	0.137%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	5,152	$36K	0.0%	+162.3%	0.008%
7/26/2024	Bank of New York Mellon Corp	186,484	$1.32M	0.0%	+62.0%	0.277%
7/20/2024	Hennion & Walsh Asset Management Inc.	102,434	$0.72M	0.0%	N/A	0.152%
5/20/2024	Virtu Financial LLC	16,372	$0.23M	0.0%	N/A	0.024%
5/16/2024	California State Teachers Retirement System	3,924	$54K	0.0%	-38.9%	0.006%
5/15/2024	NEA Management Company LLC	1,500,000	$20.63M	1.2%	N/A	2.225%
5/15/2024	Price T Rowe Associates Inc. MD	1,566,736	$21.54M	0.0%	+140.5%	2.324%
5/10/2024	Vanguard Group Inc.	2,882,055	$39.63M	0.0%	+27.9%	4.275%
5/9/2024	Monaco Asset Management SAM	130,000	$1.79M	0.5%	-53.6%	0.193%
5/8/2024	ProShare Advisors LLC	11,733	$0.16M	0.0%	N/A	0.017%
4/29/2024	China Universal Asset Management Co. Ltd.	12,922	$0.18M	0.0%	+104.9%	0.019%
2/13/2024	Tower Research Capital LLC TRC	9,255	$85K	0.0%	+19.6%	0.014%
2/7/2024	Monaco Asset Management SAM	280,000	$2.58M	0.8%	-27.2%	0.416%
2/7/2024	Vivo Capital LLC	849,681	$7.82M	0.6%	+9.2%	1.261%
2/6/2024	AJOVista LLC	4,357	$40K	0.1%	N/A	0.006%
2/6/2024	M&T Bank Corp	83,926	$0.77M	0.0%	+18.3%	0.125%
2/5/2024	Victory Capital Management Inc.	126,030	$1.16M	0.0%	+0.9%	0.187%
2/1/2024	New York State Common Retirement Fund	9,570	$88K	0.0%	-39.0%	0.014%
1/30/2024	Strs Ohio	7,900	$72K	0.0%	N/A	0.014%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	22,043	$0.20M	0.0%	+6.6%	0.040%
1/24/2024	China Universal Asset Management Co. Ltd.	6,305	$58K	0.0%	N/A	0.012%
12/1/2023	Euclidean Capital LLC	989,410	$5.99M	1.3%	+32.4%	1.814%
11/15/2023	Alkeon Capital Management LLC	3,479,289	$21.05M	0.0%	+16.8%	6.378%
11/14/2023	Sherbrooke Park Advisers LLC	11,911	$72K	0.0%	N/A	0.022%
11/13/2023	Algert Global LLC	13,430	$81K	0.0%	N/A	0.025%
11/13/2023	Acadian Asset Management LLC	22,691	$0.14M	0.0%	-86.7%	0.042%
11/13/2023	Silverarc Capital Management LLC	1,123,345	$6.80M	2.1%	-22.6%	2.059%
11/13/2023	FMR LLC	3,132,194	$18.95M	0.0%	-16.1%	5.742%
11/8/2023	Vivo Capital LLC	777,944	$4.71M	0.6%	N/A	1.427%
11/7/2023	Monaco Asset Management SAM	384,793	$2.33M	0.7%	+1.7%	0.706%
11/7/2023	Jump Financial LLC	32,149	$0.20M	0.0%	+104.8%	0.059%
11/6/2023	Victory Capital Management Inc.	124,850	$0.76M	0.0%	-8.9%	0.229%
9/21/2023	Barclays PLC	7,772	$61K	0.0%	N/A	0.014%
8/15/2023	Silverarc Capital Management LLC	1,450,822	$11.26M	3.5%	+1.0%	2.661%
8/15/2023	Suvretta Capital Management LLC	492,924	$3.83M	0.2%	-74.1%	0.904%
8/15/2023	Boxer Capital LLC	1,732,571	$13.45M	0.6%	+64.4%	3.177%
8/14/2023	ArrowMark Colorado Holdings LLC	1,417,873	$11M	0.1%	+454.4%	3.144%
8/14/2023	Prosight Management LP	2,761,468	$21.43M	6.6%	+78.7%	5.064%
8/11/2023	VR Adviser LLC	2,142,856	$16.63M	2.7%	N/A	4.752%
8/11/2023	Pale Fire Capital SE	33,055	$0.26M	0.0%	N/A	0.073%
8/8/2023	Monaco Asset Management SAM	378,222	$2.94M	0.8%	-31.5%	0.839%
8/7/2023	Acadian Asset Management LLC	170,488	$1.32M	0.0%	+30.5%	0.378%
8/4/2023	American International Group Inc.	18,787	$0.15M	0.0%	N/A	0.042%
7/27/2023	Victory Capital Management Inc.	137,030	$1.06M	0.0%	-13.5%	0.304%
7/27/2023	Virtu Financial LLC	11,831	$92K	0.0%	-39.7%	0.026%
7/10/2023	SG Americas Securities LLC	23,150	$0.18M	0.0%	N/A	0.051%
5/15/2023	Atom Investors LP	65,779	$0.38M	0.2%	-46.9%	0.146%
5/12/2023	Prosight Management LP	1,545,000	$8.81M	4.2%	+30.9%	3.426%
5/11/2023	Acadian Asset Management LLC	130,655	$0.74M	0.0%	+2.2%	0.290%
5/3/2023	Jump Financial LLC	24,349	$0.14M	0.0%	N/A	0.054%
5/2/2023	Victory Capital Management Inc.	158,430	$0.90M	0.0%	N/A	0.351%
5/1/2023	Virtu Financial LLC	19,624	$0.11M	0.0%	N/A	0.044%
2/15/2023	Alkeon Capital Management LLC	2,399,252	$14.13M	0.1%	+13.9%	6.062%
2/15/2023	Atom Investors LP	123,821	$0.73M	0.4%	-5.1%	0.313%
2/14/2023	683 Capital Management LLC	33,800	$0.20M	0.0%	N/A	0.085%
2/13/2023	GSA Capital Partners LLP	238,359	$1.40M	0.2%	+5.7%	0.602%
2/13/2023	Cornercap Investment Counsel Inc.	46,485	$0.27M	0.0%	-32.7%	0.117%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	41,635	$0.25M	0.0%	-18.1%	0.105%
2/1/2023	Bank of Montreal Can	107,688	$0.64M	0.0%	N/A	0.272%
1/31/2023	Monaco Asset Management SAM	557,430	$3.28M	0.9%	+63.4%	1.408%
11/15/2022	Prosight Management LP	936,334	$3M	1.6%	N/A	2.366%
11/14/2022	Point72 Asset Management L.P.	10,000	$32K	0.0%	N/A	0.025%
11/14/2022	Ergoteles LLC	83,835	$0.27M	0.0%	-45.2%	0.212%
11/14/2022	UBS Oconnor LLC	343,002	$1.10M	0.0%	-5.0%	0.867%
11/14/2022	Hsbc Holdings PLC	60,000	$0.19M	0.0%	+71.4%	0.152%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	50,809	$0.16M	0.0%	+141.2%	0.128%
11/8/2022	Atom Investors LP	130,541	$0.42M	0.1%	+65.8%	0.330%
10/31/2022	Monaco Asset Management SAM	341,182	$1.09M	0.4%	-6.5%	0.862%
10/28/2022	Silverarc Capital Management LLC	1,208,992	$3.87M	1.3%	+11.7%	3.055%
10/18/2022	Bailard Inc.	38,505	$0.12M	0.0%	N/A	0.097%
8/16/2022	DAFNA Capital Management LLC	415,926	$1.86M	0.5%	N/A	1.051%
8/15/2022	Laurion Capital Management LP	11,940	$53K	0.0%	N/A	0.030%
8/11/2022	Beacon Pointe Advisors LLC	10,040	$44K	0.0%	N/A	0.025%
8/8/2022	Y Intercept Hong Kong Ltd	10,828	$49K	0.0%	N/A	0.027%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	21,063	$94K	0.0%	N/A	0.053%
8/1/2022	Monaco Asset Management SAM	364,741	$1.63M	0.7%	N/A	0.924%
7/25/2022	Allspring Global Investments Holdings LLC	65,716	$0.29M	0.0%	-93.3%	0.166%
7/25/2022	Silverarc Capital Management LLC	1,082,304	$4.85M	1.5%	N/A	2.742%
5/20/2022	International Biotechnology Trust PLC	176,217	$0.91M	0.2%	+15.2%	0.446%
5/11/2022	GSA Capital Partners LLP	42,507	$0.23M	0.0%	+77.5%	0.108%
5/6/2022	Los Angeles Capital Management LLC	35,830	$0.19M	0.0%	+75.8%	0.091%
5/4/2022	Victory Capital Management Inc.	47,919	$0.16M	0.0%	-97.3%	0.121%
4/29/2022	Nisa Investment Advisors LLC	16,100	$86K	0.0%	N/A	0.041%

Data available starting January 2016

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, which is designed to selectively target epidermal growth factor receptor and human epidermal growth factor receptor 2 with high potency towards exon 20 insertion mutations; ORIC-944, an allosteric inhibitor of the polycomb repressive complex 2 for prostate cancer, currently under Phase 1b study; and ORIC-533, an orally bioavailable small molecule inhibitor of CD73, currently under Phase 1b study, being developed for resistance to chemotherapy- and immunotherapy-based treatment regimens. The company is also developing multiple discovery stage precision medicines targeting other cancer resistance mechanisms, including ORIC-613, an orally bioavailable, highly selective inhibitor of PLK4, in preclinical studies for the treatment of breast cancers. It has a license and collaboration agreement with Voronoi Inc.; a license agreement with Mirati Therapeutics, Inc.; and clinical development collaboration agreement with Pfizer Inc. The company was incorporated in 2014 and is headquartered in South San Francisco, California.

Today's Range

Now: $9.65

$9.11

$9.83

50 Day Range

MA: $9.72

$7.52

$11.90

52 Week Range

Now: $9.65

$5.27

$16.65

Volume

312,006 shs

Average Volume

530,333 shs

Market Capitalization

$650.62 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.12

Who are the company insiders with the largest holdings of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top insider shareholders include:
Jacob Chacko (CEO)
Pratik S Multani (Insider)
Learn More about top insider investors at ORIC Pharmaceuticals.
Who are the major institutional investors of ORIC Pharmaceuticals?: ORIC Pharmaceuticals' top institutional investors include:
First Turn Management LLC — 2.25%
Millennium Management LLC — 1.16%
Dimensional Fund Advisors LP — 0.69%
Monaco Asset Management SAM — 0.45%
Bank of New York Mellon Corp — 0.28%
Fred Alger Management LLC — 0.23%
Learn More about top institutional investors of ORIC Pharmaceuticals stock.
Which institutional investors are selling ORIC Pharmaceuticals stock?: During the last quarter, ORIC stock was sold by these institutional investors:
TD Asset Management Inc
Fred Alger Management LLC
Renaissance Technologies LLC
AQR Capital Management LLC
In the previous year, company insiders that have sold ORIC Pharmaceuticals company stock include:
Jacob Chacko (CEO)
Pratik S Multani (Insider)
Learn More investors selling ORIC Pharmaceuticals stock.
Which institutional investors are buying ORIC Pharmaceuticals stock?: During the previous quarter, ORIC stock was bought by institutional investors including:
Millennium Management LLC
First Turn Management LLC
Dimensional Fund Advisors LP
Monaco Asset Management SAM
Hennion & Walsh Asset Management Inc.
Bank of New York Mellon Corp
Rhumbline Advisers
Cornercap Investment Counsel Inc.